Page 1

☑ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D.C. 20549 FORM 10 - K ( Mark One ) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-204857 O CURE CURE PHARMACEUTICAL HOLDING CORP . ( Exact name of registrant as specified in its charter ) Delaware ( State or Other Jurisdiction of Incorporation or Organization ) 37-1765151 ( I.R.S. Employer Identification No. ) 1620 Beacon Place , Oxnard , California 93033 ( Address of Principal Executive Offices ) ( Zip Code ) Registrant's telephone number , including area code : ( 805 ) 824-0410 SECURITIES REGISTERED PURSUANT TO SECTION 12 ( b ) OF THE ACT : None . SECURITIES REGISTERED PURSUANT TO SECTION 12 ( g ) OF THE ACT : Title of each class : Common stock , par value $ 0.001 Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes □ No ☑ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes No ☑ Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes ☑ No □ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( § 232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . Yes ☑ No □